Feedback
European Shorting
My Portfolios
Browse Gurus
Print
Email
Biomarin Pharma has a market cap of $4 billion; its shares were traded at around $35.78 with and P/S ratio of 9.1.
This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.
CEO Recent Trades:
- CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 02/23/2012 at the average price of 35.31. Jean Jacques Bienaime owns at least 121,093 shares after this. The price of the stock has increased by 1.33% since.
- CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 09/28/2011 at the average price of 32. Jean Jacques Bienaime owns at least 126,093 shares after this. The price of the stock has increased by 11.81% since.
CFO Recent Trades:
- SVP, CFO Jeffrey H Cooper sold 83,036 shares of BMRN stock on 02/24/2012 at the average price of 35.07. Jeffrey H Cooper owns at least 40,104 shares after this. The price of the stock has increased by 2.02% since.
- SVP, CFO Jeffrey H Cooper sold 2,500 shares of BMRN stock on 01/03/2012 at the average price of 34.75. Jeffrey H Cooper owns at least 40,104 shares after this. The price of the stock has increased by 2.96% since.
- SVP, CFO Jeffrey H Cooper sold 2,500 shares of BMRN stock on 11/01/2011 at the average price of 33.26. Jeffrey H Cooper owns at least 40,104 shares after this. The price of the stock has increased by 7.58% since.
- SVP, CFO Jeffrey H Cooper sold 18,379 shares of BMRN stock on 10/10/2011 at the average price of 34. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 5.24% since.
- SVP, CFO Jeffrey H Cooper sold 18,379 shares of BMRN stock on 09/28/2011 at the average price of 32. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 11.81% since.
This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.
Directors and Officers Recent Trades:
- VP, Corporate Controller Brian Mueller sold 5,000 shares of BMRN stock on 02/24/2012 at the average price of 35.07. Brian Mueller owns at least 8,300 shares after this. The price of the stock has increased by 2.02% since.
- EVP, Technical Operations Robert Baffi sold 91,313 shares of BMRN stock on 02/24/2012 at the average price of 34.84. Robert Baffi owns at least 83,493 shares after this. The price of the stock has increased by 2.7% since.
- VP, Human Resources Mark Wood sold 1,854 shares of BMRN stock on 02/22/2012 at the average price of 35.14. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 1.82% since.
- VP, Human Resources Mark Wood sold 6,500 shares of BMRN stock on 02/02/2012 at the average price of 38. Mark Wood owns at least 20,634 shares after this. The price of the stock has decreased by 5.84% since.
- VP, Human Resources Mark Wood sold 1,854 shares of BMRN stock on 01/23/2012 at the average price of 34.96. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 2.35% since.
For the complete insider trading history of BMRN, click here.
Subscribe RSS
RSS